Skip to main content
Ivan Grunberger, MD, Urology, Brooklyn, NY

IvanGrunbergerMD

Urology Brooklyn, NY

Male Sexual Dysfunction, Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Director, Urologic Strategic Initiative, Lenox Hill Hospital, Northwell Health

Dr. Grunberger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Grunberger's full profile

Already have an account?

  • Office

    126 Greenpoint Avenue
    Brooklyn, NY 11222
    Phone+1 718-684-7466
    Fax+1 718-684-7467

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Urology, 1982 - 1986
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Surgery, 1980 - 1982
  • New York University School of Medicine
    New York University School of MedicineClass of 1980
  • Columbia College
    Columbia CollegeB.A., Molecular Biology, 1976

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1981 - 2025
  • GA State Medical License
    GA State Medical License 1992 - 2011
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • New York Magazine: Top Doctors Castle Connolly, 2002, 2006, 2009-2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies  
    Golan,R., Bernstein,A., Sedrakyan, A., Daskivich, T.J., Du, D.T., Ehdaie, B., Fisher, B., Gorin, M.A., Grunberger, I., Hunt, B., Jiang, H.H., Kim, H.L., Marinac-Dabic,..., The Journal of Urology, 1/1/2018
  • Fexapotide trifluate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement  
    Shore, N., Tutrone, R., Efros, M., Bidair, M., Wachs, B., Kalota, S., Freedman, S., Bailen, J., Levin, R., Richardson, S., Kaminetsky, J., Snyder, J., Shepard, B., Gol..., World J. of Urology, 1/1/2018
  • The Incidence of Fluoroquinolone Resistant Infections After Prostate Biopsy�Are Fluoroquinolones Still Effective Prophylaxis?  
    Feliciano, J., Teper, E., Ferrandino, M., Macchia, R.J., Blank, W., Grunberger, I., and Ivan Colon, The Journal of Urology, 1/1/2008
  • Join now to see all

Books/Book Chapters

Lectures

  • Efficacy of High Intensity Focused Ultrasound (HIFU) as a Primary Monotherapy for Low Risk Localized Prostate Cancer: Outcomes from the ENLIGHT Trial 
    1/1/2016
  • A Novel Technique for Benign Prostate Tissue Ablation � The Plasma Vaporization Electrode 
    Krakow, Poland - 1/1/2010
  • Prostate-Sparing Targeted Therapies (Cryotherapy) 
    Berlin, Germany - 1/1/2008
  • Join now to see all

Press Mentions

  • Nymox Provides Update on Regulatory Filing Activities
    Nymox Provides Update on Regulatory Filing ActivitiesNovember 16th, 2020
  • NYMOX Provides Current Update on Key Company Developments
    NYMOX Provides Current Update on Key Company DevelopmentsJuly 28th, 2020
  • Nymox Provides Update on Current Corporate Activities and Milestones
    Nymox Provides Update on Current Corporate Activities and MilestonesJanuary 28th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Czech